NCT05057949View on ClinicalTrials.gov

A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

February 17, 2022

Study Completion Date

September 28, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Larotinib

Larotinib Capsules

DRUG

Rifampin

Rifampin Capsules

DRUG

Itraconazole

Itraconazole Capsules

Trial Locations (1)

130000

First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT05057949 - A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants | Biotech Hunter | Biotech Hunter